International Pharmacovigilance Day is coming back on 12 (afternoon) and 13 (full day) September 2022 in Madrid

Scientific Board

  • Martijn van de Leur, Head of Global PV at Biomapas (Chair of the Scientific Board)
  • Martijn Dahlhaus, Head of Country PV, WorldWide Patient Safety at Bristol-Myers Squibb
  • Jørgen Matz, Head of Global Pharmacovigilance & Drug Safety, EU QPPV at InsudPharma

More details available soon!


More details available soon

Martijn van de Leur
Info Scientific Board

Martijn van de Leur

Head of Global Pharmacovigilance at Biomapas
Martijn van de Leur has over 16 years of experience in pharmacovigilance. Martijn van de Leur graduated from Radboud University as a Biomedical Scientist with specializations in Pathobiology and Oncology. Since 2005, he started to work in the life science industry, concentrating in the pharmacovigilance area. As a senior leader in pharmacovigilance and experienced (Deputy) EU QPPV, Martijn has a broad network within the industry and is a known industry speaker with excellent drug safety experience. Before joining Biomapas, he acted as Global Head of Drug Safety Compliance and Global Head of Drug Safety Technologies at Vifor Pharma, and further back in his career working as Pharmacovigilance Lead at Merck.
Martijn Dahlhaus
Info Scientific Board

Martijn Dahlhaus

Head of Country Pharmacovigilance at Bristol Myers Squibb
Martijn Dahlhaus is Head of Country Pharmacovigilance in The Netherlands at Bristol Myers Squibb. Heading the local pharmacovigilance organisation, he carries responsibility for all pharmacovigilance and risk management activities in The Netherlands and has regularly and successfully hosted PV audits. He is also deputy for Belgium and Luxembourg. Martijn has been in this role for the past 9 years, before which he held various roles in Pharmacovigilance and Medical Information at Genzyme and Novartis.  Martijn is an ACRP-certified CRA and holds a Master’s degree in Medical Biology and a PhD in Neurobiology, both from the Vrije Universiteit in Amsterdam, Netherlands.  
Jørgen Matz
Info Scientific Board

Jørgen Matz

Head of Global Pharmacovigilance & Drug Safety at InsudPharma
Jørgen Matz, MSc, PhD, PgD is the Head of Global Pharmacovigilance & Drug Safety for InsudPharma in Madrid, which is a healthcare company with business units for worldwide manufacturing, development, and marketing of branded, generic and biotechnological products. Jorgen Matz has been in the pharmaceutical industry for about 25 years, hereof 15 years in Global Pharmacovigilance & Drug Safety. He has a background as an experimental pharmacologist and his focus areas in recent year has been on implementing pharmacovigilance systems tailored to support ICSR processing and continuous benefit-risk assessments of marketed products.

Francesca Archetti
Events and Training Manager

Roberta Alberti
Events and Training Assistant

Registration Fee

€ 945,00*      Super Early Bird fee until 12 June 2022
€ 980,00*      Early Bird fee until 12 August 2022
€ 1.190,00*   Ordinary fee
€ 730,00*      Freelance, Academy, Public Administration

* for Italian companies: +22% VAT

Fee includes: seat at the conference, copy of presentations of Speakers who allow the distribution, 1 networking lunch, 3 coffee breaks, organisational office assistance, certificate of attendance.

Past Conferences
Pharmacovigilance Within and Without Borders
A Global Pharmacovigilance Network: Opportunities and Challenges
Evolvement of Pharmacovigilance Today and in the Near Future
Become Sponsor Printable Version

Madrid – Spain
The conference location will be announced soon.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.